Medigen Biotechnology
TWD31.80
0
-TWD1.40-4.22% 05:30 Today
Statistics
Day High
33.15
Day Low
31.8
52W High
43.6
52W Low
28.2
Volume
371,106
Avg. Volume
630,760
Mkt Cap
4.43B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-6.88%Profit Margin
Unprofitable1.58BRevenue
-108.8MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
Show More
CEO
Shi-Chung Chang
Employees
67
Country
Taiwan
ISIN
TW0003176004
Listings
0 Comments
Share your thoughts
FAQs
What is Medigen Biotechnology stock price today?▼
The current price of 3176.TWO is TWD31.80 TWD — it has decreased by -4.22% in the past 24 hours. Watch Medigen Biotechnology stock price performance more closely on the chart.
What is Medigen Biotechnology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Medigen Biotechnology stocks are traded under the ticker 3176.TWO.
Is Medigen Biotechnology stock price growing?▼
3176.TWO stock has fallen by -4.79% compared to the previous week, the month change is a -15.31% fall, over the last year Medigen Biotechnology has showed a +8.16% increase.
What is Medigen Biotechnology market cap?▼
Today Medigen Biotechnology has the market capitalization of 4.43B
What is Medigen Biotechnology revenue for the last year?▼
Medigen Biotechnology revenue for the last year amounts to 1.58B TWD.
What is Medigen Biotechnology net income for the last year?▼
3176.TWO net income for the last year is -108.8M TWD.
How many employees does Medigen Biotechnology have?▼
As of November 3, 2026, the company has 67 employees.
In which sector is Medigen Biotechnology located?▼
Medigen Biotechnology operates in the Health & Wellness sector.
When did Medigen Biotechnology complete a stock split?▼
Medigen Biotechnology has not had any recent stock splits.
Where is Medigen Biotechnology headquartered?▼
Medigen Biotechnology is headquartered in Taipei, Taiwan.